January 2019

Regardless of whether they suggested revisions to latest standards, they must prepare for new compounding regulations.

How to treat hepatocellular carcinoma is heavily influenced by the burden of disease at diagnosis.

The newly FDA-approved drug blocks viral replication and RNA transcription via a cap-dependent endonuclease inhibitor.

Is piperacillin/tazobactam an effective carbapenem alternative to treat bloodstream infections caused by ESBL-producing enterobacteriaceae.

In the United States, about 13% of patients present with advanced melanoma (9% with regional disease and 4% with distant metastatic disease).

A comprehensive approach requires that patients play an active role in determining medication and nonpharmacologic treatments.

I fully recognize that we want pharmacists who bring specialized knowledge and skills, such as critical care, infectious diseases, or oncology, to be involved as a patient progresses through the health care system, but it is obvious that we also fractionate care when it is not ideal or necessary.